Patents by Inventor Juan A. Gamboa

Juan A. Gamboa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR GENERATING ACID ANHYDRIDES
    Publication number: 20230120038
    Abstract: Provided is a method of producing an anhydride of an organic mono-acid comprising contacting an organic mono-acid and a thermally regenerable anhydride to produce the anhydride of the organic mono-acid, and either a diacid of the regenerable anhydride, a partially hydrolyzed regenerable anhydride, or both. In a particular example, acetic acid and glutaric anhydride can be reacted to form acetic anhydride.
    Type: Application
    Filed: December 17, 2022
    Publication date: April 20, 2023
    Applicant: Hyconix, Inc.
    Inventors: Johnathan Gorke, Brian Hashiguchi, Michael Konnick, Jeffrey Elks, Jeremy Patt, Juan Gamboa
  • Process for generating acid anhydrides
    Patent number: 11608306
    Abstract: Provided is a method of producing an anhydride of an organic mono-acid comprising contacting an organic mono-acid and a thermally regenerable anhydride to produce the anhydride of the organic mono-acid, and either a diacid of the regenerable anhydride, a partially hydrolyzed regenerable anhydride, or both. In a particular example, acetic acid and glutaric anhydride can be reacted to form acetic anhydride.
    Type: Grant
    Filed: May 7, 2021
    Date of Patent: March 21, 2023
    Assignee: Hyconix, Inc.
    Inventors: Johnathan Gorke, Brian Hashiguchi, Michael Konnick, Jeffrey Elks, Jeremy Patt, Juan Gamboa
  • PROCESS FOR GENERATING ACID ANHYDRIDES
    Publication number: 20210347722
    Abstract: Provided is a method of producing an anhydride of an organic mono-acid comprising contacting an organic mono-acid and a thermally regenerable anhydride to produce the anhydride of the organic mono-acid, and either a diacid of the regenerable anhydride, a partially hydrolyzed regenerable anhydride, or both. In a particular example, acetic acid and glutaric anhydride can be reacted to form acetic anhydride.
    Type: Application
    Filed: May 7, 2021
    Publication date: November 11, 2021
    Applicant: Hyconix, Inc.
    Inventors: Johnathan Gorke, Brian Hashiguchi, Michael Konnick, Jeffrey Elks, Jeremy Patt, Juan Gamboa
  • Synthesis of piperidine and piperazine compounds as CCR5 antagonists
    Patent number: 6992189
    Abstract: In its several embodiments, this invention discloses novel processes to prepare the compounds of formula II and formula IV:
    Type: Grant
    Filed: March 27, 2003
    Date of Patent: January 31, 2006
    Assignee: Schering Corporation
    Inventors: William Leong, Minzhang Chen, Bosco A. D'sa, Man Zhu, Tong Xiao, Xiongwei Shi, Suhan Tang, Dinesh Gala, Andrew J. Goodman, Christopher M. Nielsen, Gary M. Lee, Juan A. Gamboa, Andrew D. Jones
  • Synthesis of piperidine and piperazine compounds as CCR5 antagonists
    Publication number: 20050187248
    Abstract: In its several embodiments, this invention discloses novel processes to prepare the compounds of formula II and formula IV:
    Type: Application
    Filed: March 24, 2005
    Publication date: August 25, 2005
    Inventors: William Leong, Minzhang Chen, Bosco D'sa, Man Zhu, Tong Xiao, Xiongwei Shi, Suhan Tang, Dinesh Gala, Andrew Goodman, Christopher Nielsen, Gary Lee, Juan Gamboa, Andrew Jones
  • Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon
    Publication number: 20050131012
    Abstract: The present invention discloses and claims compounds of formula (I) as inhibitors of human casein kinase IF, and methods of using said compounds of formula (I) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. Pharmaceutical compositions comprising compounds of formula (I) and methods for the preparation of compounds of formula (I) are also disclosed and claimed.
    Type: Application
    Filed: December 1, 2004
    Publication date: June 16, 2005
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: William Metz, Frank Halley, Gilles Dutruc-Rosset, Yong Choi-Sledeski, Gregory Bernard Poli, David Fink, Gilles Doerflinger, Bao-Guo Huang, Ann Gelormini, Juan Gamboa, Andrew Giovanni, Joachim Roehr, Joseph Tsay, Fernando Camacho, William Hurst, Stephen Harnish, Yulin Chiang
  • Synthesis of piperidine and piperazine compounds as CCR5 antagonists
    Publication number: 20040024217
    Abstract: In its several embodiments, this invention discloses novel processes to prepare the compounds of formula II and formula IV: 1
    Type: Application
    Filed: March 27, 2003
    Publication date: February 5, 2004
    Applicant: Schering Corporation
    Inventors: William Leong, Minzhang Chen, Bosco A. D'sa, Man Zhu, Tong Xiao, Xiongwei Shi, Suhan Tang, Dinesh Gala, Andrew J. Goodman, Christopher M. Nielsen, Gary M. Lee, Juan A. Gamboa, Andrew D. Jones